ArticleBritish journal of cancer2013

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer.

R K Kelley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.